Thrombomodulin alters the active site loops of thrombin to shift its substrate specificity toward protein C activation, providing a structural mechanism for its anticoagulant function.
Answers are grounded in this paper and cite their sources.
Structural mechanism for thrombomodulin identified in vitro; leaves open translation to human antithrombotic strategies.
Thrombomodulin (TM) forms a 1:1 complex with thrombin. Whereas thrombin alone cleaves fibrinogen to make the fibrin clot, the thrombin-TM complex cleaves protein C to initiate the anticoagulant pathway. Crystallographic investigations of the complex between thrombin and TMEGF456 did not show any changes in the thrombin active site. Therefore, research has focused recently on how TM may provide a docking site for the protein C substrate. Previous work, however, showed that when the thrombin active site was occupied with substrate analogues labeled with fluorophores, the fluorophores responded differently to active (TMEGF1-6) versus inactive (TMEGF56) fragments of TM. To investigate this further, we have carried out amide H/(2)H exchange experiments on thrombin in the presence of active (TMEGF45) and inactive (TMEGF56) fragments of TM. Both on-exchange and off-exchange experiments show changes in the thrombin active site loops, some of which are observed only when the active TM fragment is bound. These results are consistent with the previously observed fluorescence changes and point to a mechanism by which TM changes the thrombin substrate specificity in favor of protein C cleavage.
No takes yet. Share an insight, caveat, or question.
Koeppe et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: